Request Demo
Last update 25 May 2025
Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Last update 25 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Amlodipine/ezetimibe/losartan/rosuvastatin, HCP 1701, HCP-1701 |
Action antagonists, inhibitors, blockers |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), NPC1L1 inhibitors(Niemann-Pick C1-like protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC22H23ClKN6O |
InChIKeyFDKIDFYIEWFERB-UHFFFAOYSA-N |
CAS Registry124750-99-8 |
View All Structures (4)
Related
3
Clinical Trials associated with Amlodipine/Losartan/Rosuvastatin/EzetimibeNCT04074551
A Randomized, Double-blinded, Multi-center, Phase III Study to Compare The Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
NCT04322266
An Open-Label, Randomized, Single-Dose Crossover Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects
NCT00457275
A Multicentre, Open-Label, Observational Local Study to Evaluate the LDL-C Lowering Effect of Ezetimibe as Prescribed in Daily Routine Practice in the South African Population
100 Clinical Results associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data
100 Translational Medicine associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data
100 Patents (Medical) associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data
100 Deals associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Dyslipidemias | South Korea | - | |
| Hypertension | South Korea | - |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Essential Hypertension | Phase 3 | United States | 16 Jul 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free